Bingül Emre Sertaç, Savran Karadeniz Meltem, Şentürk Emre, Vuran Yaz İrem, Atasever Ayşe Gülşah, Orhan Sungur Mukadder
Department of Anaesthesiology and Reanimation, Istanbul University Istanbul Faculty of Medicine, Millet St. Surgical Sciences Building, 34093 Istanbul, Turkey.
Department of Anaesthesiology, KU Leuven, 3000 Leuven, Belgium.
Medicina (Kaunas). 2025 Apr 24;61(5):786. doi: 10.3390/medicina61050786.
: Metabolic-flow (<0.35 L/min) anesthesia is practiced more often as manufacturers provide newer technologies, yet the benefits of metabolic-flow anesthesia have not been fully investigated. This study aimed to investigate the feasibility and safety of automated gas control (AGC) mode, which provides metabolic-flow anesthesia, in a pediatric population. : Pediatric surgery patients between 1 and 10 years of age were included in this prospective observational trial. After intravenous induction and safe orotracheal intubation, AGC was initiated, and total sevoflurane consumption (mL) and wash-in speed-based sevoflurane consumption data were collected to measure feasibility. For safety, inspired (FO), alveolar (FO), and expired (FO) oxygen concentration data, and inspired and alveolar sevoflurane (FSevo and FSevo, respectively) concentration data, were recorded. Changes in fresh gas flow (FGF) throughout the procedure and postoperative recovery data were also compared. : A total of 130 patients were eligible for this study, and 121 patients were included in the analyses; 30 patients had a wash-in speed of 4 (WI4) and 91 patients had a wash-in speed of 8 (WI8) at follow-up. The total mean sevoflurane consumption was 9.35 ± 4.93 mL for a median surgery duration of 100 min. WI8 patients consumed more sevoflurane (9.92 ± 5.08 mL vs. 7.79 ± 4.19 mL, = 0.04). At the 15th and 30th minutes, the FGF dropped under minimal flow and metabolic flow limits, respectively ( < 0.001). The times to extubation and obeying commands were shorter in WI8 patients (8 (5-10) vs. 11 (5-15) = 0.03, and 9.5 (5-10.5) vs. 13 (9-17) < 0.01). : Maintenance with AGC may offer up to 40 h of anesthesia, considering that the volume of a sevoflurane bottle is 250 mL, reflecting exceptional savings compared to conventional anesthesia management. Metabolic flow anesthesia driven by AGC is feasible and safe in pediatric anesthesia practice.
随着制造商推出更新的技术,代谢流量(<0.35升/分钟)麻醉的应用越来越频繁,但代谢流量麻醉的益处尚未得到充分研究。本研究旨在探讨提供代谢流量麻醉的自动气体控制(AGC)模式在儿科患者中的可行性和安全性。
1至10岁的小儿外科手术患者被纳入这项前瞻性观察性试验。静脉诱导并安全进行口气管插管后,启动AGC,并收集七氟醚总消耗量(毫升)和基于洗入速度的七氟醚消耗数据以评估可行性。为评估安全性,记录吸入(FO)、肺泡(FAO)和呼出(FEO)氧浓度数据,以及吸入和肺泡七氟醚(分别为FSevo和FASevo)浓度数据。还比较了整个手术过程中新鲜气体流量(FGF)的变化和术后恢复数据。
共有130例患者符合本研究条件,121例患者纳入分析;30例患者随访时洗入速度为4(WI4),91例患者随访时洗入速度为8(WI8)。手术中位时长100分钟时七氟醚总平均消耗量为9.35±4.93毫升。WI8组患者七氟醚消耗量更多(9.92±5.08毫升对7.79±4.19毫升,P = 0.04)。在第15分钟和第30分钟时,FGF分别降至最低流量和代谢流量限制以下(P < 0.001)。WI8组患者拔管时间和能听从指令的时间更短(8(5 - 10)分钟对11(5 - 15)分钟,P = 0.03;9.5(5 - 10.5)分钟对13(9 - 17)分钟,P < 0.01)。
考虑到一瓶七氟醚的容量为250毫升,采用AGC维持麻醉可达40小时,与传统麻醉管理相比节省显著。AGC驱动的代谢流量麻醉在小儿麻醉实践中是可行且安全的。